Resource Table.
| Unique stem cell line identifier | TRNDi001-D |
| Alternative name(s) of stem cell line | HT307D |
| Institution | National Institutes of Health |
| National Center for Advancing Translational Sciences | |
| Bethesda, Maryland, USA | |
| Contact information of distributor | Dr. Wei Zheng Wei.Zheng@nih.gov |
| Type of cell line | iPSC |
| Origin | Human |
| Additional origin info | Age: N/A |
| Sex: Male | |
| Ethnicity: N/A | |
| Cell Source | Fibroblasts |
| Clonality | Clonal |
| Method of reprogramming | Integration-free Sendai viral vectors |
| Genetic Modification | NO |
| Type of Modification | N/A |
| Associated disease | Niemann-Pick disease, type C1 (NPC1) |
| Gene/locus | Gene: NPC1 |
| Locus: 18q11-q12 | |
| Mutation: Homozygous, NPC1, c. 3182T>C, p. I1061T | |
| Method of modification | N/A |
| Name of transgene or resistance | N/A |
| Inducible/constitutive system | N/A |
| Date archived/stock date | 2016 |
| Cell line repository/bank | N/A |
| Ethical approval | NIGMS Informed Consent Form was obtained from patient at time of sample submission. |
| Confidentiality Certificate: CC-GM-15–004 |